Home Medical RegeneratOR Test Bed announces partnership with Cytoink

RegeneratOR Test Bed announces partnership with Cytoink

RegeneratOR Test Bed expands its ecosystem with specialist Cytoink to advance biomedical research and development. Cytoink brings state-of-the-art biomaterials with over 100 customized formulations and bioprinting expertise.

Cytoink is committed to shaping the future of biomedical research and development by prioritizing precision and efficiency. Its innovative solutions aim to accelerate scientific progress while ensuring robust and reliable results. Bioinks, which are used to produce complex tissues, consist of living cells suspended in polymers or hydrogels. These “inks” are used in printing devices to formulate scaffolds for cell proliferation or entire 3D-printed organs and tissues.

“At Cytoink, we envision a future where accuracy and speed are the cornerstones of biomedical research, driving impactful healthcare outcomes,” said Martin Tomov, co-founder of Cytoink. “We are thrilled to join the RegeneratOR Test Bed, a hub of innovation that aligns perfectly with our mission to empower research and industry leaders worldwide.”

The RegeneratOR Test Bed, operated by the RegenMed Development Organization (ReMDO), is known for fostering collaborative environments where advanced technologies come together to advance regenerative medicine and biomedical engineering. By adding Cytoink to its ecosystem, Test Bed continues to expand its capabilities and influence in the biomedical community.

“We are excited to welcome Cytoink to the Test Bed,” said Joshua Hunsberger, CTO of ReMDO. “Their expertise in biomaterials and commitment to innovation aim to accelerate the development of technologies that benefit both researchers and patients.”

The integration of Cytoink into the RegeneratOR Test Bed represents another step in building and supporting the Piedmont Triad RegenMed Engine, part of the National Science Foundation (NSF) Innovation Engines program. In this ecosystem, biomedical innovation research is working to set new standards in biotechnology and facilitate breakthroughs that improve global health outcomes.


Subscribe to our Newsletter

3DPresso is a weekly newsletter that links to the most exciting global stories from the 3D printing and additive manufacturing industry.

Privacy Policy*
 

You can find the privacy policy for the newsletter here. You can unsubscribe from the newsletter at any time. For further questions, you can contact us here.